Format

Send to

Choose Destination
See comment in PubMed Commons below
Nat Rev Genet. 2004 Sep;5(9):676-80.

Pharmacogenetics: ethical problems and solutions.

Author information

1
UK Medicines and Healthcare products Regulatory Agency.

Abstract

Regulators, drug companies, academic scientists, bioethicists, clinicians and, increasingly, the general public are starting to realize that pharmacogenetics (PGx) will probably have a huge impact on the way in which we treat both common and rare diseases. But how much thought has gone into the ethical issues that the incorportation of phamacogenetic testing into drug discovery, prescription and use will entail? It seems that "quite a bit" is the answer, as the diverse viewpoints of representatives of all of these groups presented here illustrate. However, these views also highlight that now is the time to start formulating and implementing solutions to these potential problems.

PMID:
15372090
DOI:
10.1038/nrg1431
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Nature Publishing Group
    Loading ...
    Support Center